Challenges with cancer pain management: novel opioid shortages and cancer trials restrictions
Journal Title
BMJ Supportive & Palliative Care
Publication Type
Online publication before print
Abstract
Patients with advanced cancer often experience bothersome symptoms requiring specialist palliative care input. Oncology clinical trials commonly include a list of prohibited medications while on trial, to avoid potential drug interactions with the investigational product. This case series illustrates how recent opioid shortages combined with prohibited opioids in clinical trials significantly impacted cancer pain control and quality of life. These cases highlight the need for cancer trial protocols to closely consider the potential impact of prohibited medication lists on optimal pain management for patients with cancer.
Keywords
Cancer; Pain; Palliative Care
Department(s)
Palliative Care
Terms of Use/Rights Notice
Refer to copyright notice on published article.


Creation Date: 2025-01-23 02:18:59
Last Modified: 2025-01-23 02:30:24

© 2025 The Walter and Eliza Hall Institute of Medical Research. Access to this website is subject to our Privacy Policy and Terms of Use

An error has occurred. This application may no longer respond until reloaded. Reload 🗙